- Home
- ITRG vs GNTA Comparison
ITRG vs GNTA Comparison
Compare ITRG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | GNTA |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 874.5M | 34.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRG | GNTA |
|---|---|---|
| Price | $3.19 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.13 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 53.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $733.38 | N/A |
| Revenue Next Year | $46.00 | N/A |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $0.71 |
| 52 Week High | $4.87 | $10.00 |
Technical Indicators
Market Signals| Indicator | ITRG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.13 | 39.45 |
| Support Level | $2.62 | $0.71 |
| Resistance Level | $3.30 | $1.70 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 1.55 | 17.75 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.